|
AKT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.271000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.444700E-03 |
| Normal-vs-Stage2 |
7.686000E-01 |
| Normal-vs-Stage3 |
8.866600E-01 |
| Normal-vs-Stage4 |
1.352370E-01 |
| Stage1-vs-Stage2 |
1.224170E-02 |
| Stage1-vs-Stage3 |
2.185600E-02 |
| Stage1-vs-Stage4 |
1.98509999999041E-05 |
| Stage2-vs-Stage3 |
7.104400E-01 |
| Stage2-vs-Stage4 |
3.672400E-01 |
| Stage3-vs-Stage4 |
1.511820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.366200E-01 |
| Normal-vs-AfricanAmerican |
1.938900E-03 |
| Normal-vs-Asian |
4.194200E-02 |
| Caucasian-vs-AfricanAmerican |
9.010400E-04 |
| Caucasian-vs-Asian |
1.630250E-01 |
| AfricanAmerican-vs-Asian |
9.607200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.198800E-01 |
| Normal-vs-Female |
2.951700E-02 |
| Male-vs-Female |
3.342000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.988770E-01 |
| Normal-vs-Age(41-60Yrs) |
9.904400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.342000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.320400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.834800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.247800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.073000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.021000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.722800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.71700000000308E-05 |
| Normal-vs-Grade 2 |
2.061600E-02 |
| Normal-vs-Grade 3 |
9.187000E-01 |
| Normal-vs-Grade 4 |
3.021000E-01 |
| Grade 1-vs-Grade 2 |
9.022900E-04 |
| Grade 1-vs-Grade 3 |
3.72539999999866E-05 |
| Grade 1-vs-Grade 4 |
2.26199999997512E-06 |
| Grade 2-vs-Grade 3 |
1.451580E-02 |
| Grade 2-vs-Grade 4 |
1.876720E-03 |
| Grade 3-vs-Grade 4 |
2.569200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.020200E-01 |
| Normal-vs-ccB subtype |
2.764400E-01 |
| ccA subtype-vs-ccB subtype |
5.288000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.840000E-01 |
| Normal-vs-N1 |
5.004200E-02 |
| N0-vs-N1 |
8.466400E-02 |
|
|
